Digestive System

Publication Title: 
Mikrobiologicheski? Zhurnal
Author(s): 
Kvasnikov, E. I.
Grigorov, Iu G.
Kovalenko, N. K.
Medovar, B. Ia
Shishlevskaia, T. N.
Palekha, S. I.
Kozlovskaia, S. M.
Publication Title: 
Annual Review of Genetics

The digestive tract plays a central role in the digestion and absorption of nutrients. Far from being a passive tube, it provides the first line of defense against pathogens and maintains energy homeostasis by exchanging neuronal and endocrine signals with other organs. Historically neglected, the gut of the fruit fly Drosophila melanogaster has recently come to the forefront of Drosophila research.

Author(s): 
Lemaitre, Bruno
Miguel-Aliaga, Irene
Publication Title: 
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica

In the central nervous system, ZM decreased locomotor activity and potentiated hypnosis of hexobarbital-Na in mice. ZM had little hypothermic action and there were no anticonvulsive effects on chemoconvulsion and electroconvulsion shock. ZM, 3 mg/kg i.v. produced a sleep-like pattern in the spontaneous EEG activity of cat; from 20 to 30 min. after injection, spindle burst-like waves (12-13 Hz) appeared in the cortex and subcortex. These EEG activities were antagonized by atropine sulfate.

Author(s): 
Suzuki, Y.
Kajiyama, K.
Taguchi, K.
Hagiwara, Y.
Imada, Y.
Publication Title: 
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica

KB-509, a new derivative of benzodiazepines, increased locomotor activities of mice in doses of 8-32 mg/kg (p.o.) and a decrease occurred with higher doses. This drug was 3-6 and 1-2 times more potent than diazepam (DZP) and nitrazepam (NZP), respectively, in anticonvulsant (anti-pentylenetetrazol, bemegride, strychnine) activities, antiaggressive activity and potentiation of chlorprothixene-induced hypnosis in mice.

Author(s): 
Sukamoto, T.
Aikawa, K.
Itoh, K.
Nose, T.
Publication Title: 
Arzneimittel-Forschung

The general pharmacological profile of 7-fluoro-1-methyl-3-(methylsulfonyl)- 4(1H)-quinolone BTS 53 554, CAS 76568-68-8), the main metabolite of a new vasodilator, flosequinan (BTS 49 465), was investigated. 1. The central nervous system: BTS 53 554 at the dose of 30 mg/kg i.v. caused an increase in respiratory rate and a sedation in general behavior in rats. The drug also inhibited acetic acid-induced writhing and slightly decreased normal body temperature in mice. However, the drug at the doses up to 30 mg/kg i.v.

Author(s): 
Fujita, S.
Ikezono, K.
Umezato, M.
Hosoki, E.
Toba, Y.
Ishikawa, M.
Kusunoki, A.
Shintani, S.
Publication Title: 
Arzneimittel-Forschung

Pharmacological effects of a new vasodilator, flosequinan (7-fluoro-1-methyl-3-(methylsulfinyl)-4(1H)-quinolone, BTS 49 465, CAS 76568-02-0) on the central nervous system, somatic nervous system, autonomic nervous system and smooth muscle, digestive system and miscellaneous organs were investigated. 1. The central nervous system: Flosequinan inhibited acetic acid-induced writhing at doses of more than 30 mg/kg p.o. and decreased body temperature and tended to decrease spontaneous movement slightly in mice at a dose of 100 mg/kg p.o.

Author(s): 
Ikezono, K.
Fujita, S.
Umezato, M.
Hosoki, E.
Toba, Y.
Kusunoki, A.
Shintani, S.
Publication Title: 
Arzneimittel-Forschung

The general pharmacological properties of a novel cholecystokinin-A antagonist, loxiglumide ((+/-)-4-(3,4-dichlorobenzamido)-N-(3-methoxypropyl)-N-pentylgl utaramic acid, CR 1505, CAS 107097-80-3) on central nervous system, autonomic nervous system, cardio-respiratory system, gastrointestinal system, hematological and miscellaneous systems were investigated in experimental animals. 1. Central nervous system: At a dose of 30 mg/kg, i.v. loxiglumide showed ptosis in one of 6 mice, but at doses of 3 and 10 mg/kg, i.v. no change on gross behavior in mice.

Author(s): 
Saito, T.
Ukai, K.
Masuda, T.
Nakagawa, T.
Kimura, K.
Fujii, M.
Wakatsuki, K.
Saeki, M.
Kasai, H.
Publication Title: 
Applied Psychophysiology and Biofeedback

This study was conducted to evaluate the comparative effect of yogic and conventional treatment in diarrhea-predominant irritable bowel syndrome (IBS) in a randomized control design. The patients were 22 males, aged 20-50 years, with confirmed diagnosis of diarrhea-predominant IBS.

Author(s): 
Taneja, Indu
Deepak, K. K.
Poojary, G.
Acharya, I. N.
Pandey, R. M.
Sharma, M. P.
Publication Title: 
Journal of Ethnopharmacology

The decoction of the leaves of Nyctanthes arbor tristis Linn. (Harsingar) is widely used in Ayurvedic system of medicine for the treatment of sciatica, arthritis, fevers, various painful conditions and as laxative. In the present investigation, the water soluble portion of the alcoholic extract of the leaves was screened for some CNS activities (viz. hypnotic, tranquilizing, local anaesthetic, hypothermic, anticonvulsant), antihistaminic and purgative activities.

Author(s): 
Saxena, R. S.
Gupta, B.
Lata, S.
Publication Title: 
The American Journal of Physiology

To investigate whether brain leptin involves neuropeptidergic pathways influencing ingestion, metabolism, and gastrointestinal functioning, leptin (3.5 micrograms) was infused daily into the third cerebral ventricular of rats for 3 days. To distinguish between direct leptin effects and those secondary to leptin-induced anorexia, we studied vehicle-infused rats with food available ad libitum and those that were pair-fed to leptin-treated animals.

Author(s): 
van Dijk, G.
Seeley, R. J.
Thiele, T. E.
Friedman, M. I.
Ji, H.
Wilkinson, C. W.
Burn, P.
Campfield, L. A.
Tenenbaum, R.
Baskin, D. G.
Woods, S. C.
Schwartz, M. W.

Pages

Subscribe to RSS - Digestive System